CNS and pituitary effects of hypothalamic peptides and MSH.
The first part of this essay discussed the CNS effects of the pituitary peptide MSH. These investigations anticipated studies of the CNS effects of peptides found in the hypothalamus which were discussed in the second part of the essay. Some of the endocrine actions of the hypothalamic peptides upon the release of pituitary hormones were discussed in the last part of the essay. Together, the CNS and pituitary effects of hypothalamic peptides and MSH provide intriguing examples of areas of investigation which can be expected to be greatly expanded in the future.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects*; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D013007:Growth Hormone-Releasing Hormone / Q000494:pharmacology; D006801:Humans; D007028:Hypothalamic Hormones / Q000494:pharmacology*; D009075:MSH Release-Inhibiting Hormone / Q000494:pharmacology; D009074:Melanocyte-Stimulating Hormones / Q000494:pharmacology*; D010902:Pituitary Gland / Q000187:drug effects*; D051381:Rats; D013004:Somatostatin / Q000494:pharmacology; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D007028:Hypothalamic Hormones; D007987:Gonadotropin-Releasing Hormone; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone; D000324:Adrenocorticotropic Hormone; D009074:Melanocyte-Stimulating Hormones; D013007:Growth Hormone-Releasing Hormone; D009075:MSH Release-Inhibiting Hormone